- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05675267
Interest of the HEART Score for the Management of Patients With Chest Pain in Emergency Department (HEART-SAU)
December 29, 2022 updated by: Université de Reims Champagne-Ardenne
Chest pain is a frequent reason of consultation in emergency department.
Emergency physician have to identify patients at high risk of Acute Coronary Syndrome from those presenting a lower risk.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
The aim of the study is to study the interest of the HEART score for the management of patients with chest pain in emergency department
Study Type
Observational
Enrollment (Anticipated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Pierre Willem, Dr
- Phone Number: +33 0326696048
- Email: pwillem@ch-chalonsenchampagne.fr
Study Contact Backup
- Name: Pierre Willem
- Phone Number: +33 0326696048
- Email: pwillem@ch-chalonsenchampagne.fr
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
patient with chest pain consulting in emergency department
Description
Inclusion Criteria:
men and women Aged more than 18 Chest pain Consulting in emergency department Agreeing to participate to the study
Exclusion Criteria:
aged less than 18 not agreeing to participate to the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
patient with chest pain
|
HEART score calculation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
HEART score
Time Frame: Day 0
|
Cardiovascular risk evaluated using HEART score.
HEART score includes 5 items on history of chest pain, electrocardiogram, patient's age, cardiovascular risk factors and initial troponin.
Each item is coded from 0 to 2 points, the overall score ranges from 0 to 10 points.
Score between 0 and 3 indicated low risk of major adverse cardiovascular event, Score between 4 and 6 indicated moderate risk of major adverse cardiovascular event, Score between 7 and 10 indicated high risk of major adverse cardiovascular event
|
Day 0
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
January 10, 2023
Primary Completion (Anticipated)
July 1, 2023
Study Completion (Anticipated)
September 1, 2023
Study Registration Dates
First Submitted
December 29, 2022
First Submitted That Met QC Criteria
December 29, 2022
First Posted (Estimate)
January 9, 2023
Study Record Updates
Last Update Posted (Estimate)
January 9, 2023
Last Update Submitted That Met QC Criteria
December 29, 2022
Last Verified
December 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022_RIPH_019_HEART-SAU
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Coronary Syndrome
-
Chulalongkorn UniversityCompletedCKD | Coronary Angiography (CAG) | ACS (Acute Coronary Syndrome)
-
Samsung Medical CenterNot yet recruitingAcute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
-
Mahidol UniversityNot yet recruitingCoronary Artery Disease | Acute Coronary Syndrome/ Myocardial InfarctionThailand
-
Shenyang Northern HospitalNot yet recruitingSGLT2 Inhibitors | ACS (Acute Coronary Syndrome)China
-
Aarhus University Hospital SkejbyAbbottEnrolling by invitationIschemic Heart Disease | Ischemic Coronary Artery Disease | ACS (Acute Coronary Syndrome)Denmark, Belgium, Germany, Finland, Sweden, Switzerland, Latvia, Norway, United Kingdom, Estonia, Netherlands, Italy
-
Heart Care FoundationNovartis Farma S.p.A.Not yet recruitingAcute Coronary Syndromes | Chronic Coronary SyndromesItaly
-
University of GalwayNot yet recruitingMyocardial Ischemia | Percutaneous Coronary Intervention | Chronic Coronary Syndrome | Coronary Computed Tomography Angiography | Acute Coronary Syndromes (ACS) | Coronary Arteries Disease
-
Yonsei UniversityRecruitingCoronary Artery Disease, Acute Coronary SyndromeKorea, Republic of
-
Xiling QiRecruitingHF - Heart Failure | ACS (Acute Coronary Syndrome)China
-
Tongji HospitalRecruiting
Clinical Trials on data collection
-
Care Management PlusCompletedHealth Information Technology | Nurse Based Care ManagementUnited States
-
M.D. Anderson Cancer CenterUnknownPediatric CancerUnited States
-
GlaxoSmithKlineCompletedInfections, StreptococcalRomania, Slovenia, Poland, Lithuania, Estonia
-
GCS Ramsay Santé pour l'Enseignement et la RechercheCompleted
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinCompleted
-
Hospices Civils de LyonCompleted
-
Women and Infants Hospital of Rhode IslandTerminated
-
Centre Hospitalier Universitaire DijonCompletedCoronary Artery Bypass Graft | Anomalies in Glucose MetabolismFrance
-
Xuanwu Hospital, BeijingRecruitingMultiple Sclerosis | Myasthenia Gravis | Autoimmune Encephalitis | Acute Disseminated Encephalomyelitis | NMO Spectrum Disorder | Myelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseChina
-
Centre Hospitalier Universitaire de Saint EtienneRecruitingCerebrospinal; DisorderFrance